" 20.117 
new drug information. 
(a) the following computer printouts are available for public inspection in the food and drug administration's freedom of information public room: 
(1) a numerical listing of all new drug applications and abbreviated new drug applications approved since 1938, showing the nda number, the trade name, the applicant, the approval date, and, where applicable, the date the approval was withdrawn and the date the food and drug administration was notified that marketing of the product was discontinued. 
(2) a numerical listing of all new drug applications and abbreviated new drug applications approved since 1938 which are still approved, showing the same information as is specified in paragraph (a)(1) of this section except that it does not show a withdrawal date. 
(3) a listing of new drug applications, abbreviated new drug applications, which were approved since 1938 and which are still approved, covering marketed prescription drug products except prescription drug products covered by applications deemed approved under the drug amendments of 1962 and not yet determined to be effective in the drug efficacy study implementation program. the listing includes the name of the active ingredient, the type of dosage form, the route of administration, the trade name of the product, the name of the application holder, and the strength or potency of the product. the listing also includes, for each active ingredient in a particular dosage form for which there is more than one approved application, an evaluation of the therapeutic equivalence of the drug products covered by such applications. 
(b) other computer printouts containing ind and nda information are available to the extent that they do not reveal data or information prohibited from disclosure under  20.61, 312.130, and 314.430 of this chapter. 

